Treating Cancer: Learn about cancer immunotherapy and explore where the field is headed — January 2026 cohort
6 January-10 February 2026
Tuesdays, 9:30pm EST/6:30pm PST; six one-hour sessions.
by Polygence
Explore cancer immunotherapy through expert-led discussions and research reading, then write a review of its use in a cancer type you choose.
See Succeed's assessment of the programme, who it may suit, the estimated total cost, what applying involves and what is still to confirm.
or let us know if .
What Succeed checks
We review public online program details such as eligibility, age range, cost, duration, learning format, scheduling, mentor model, outputs and application timing.
What Last verified means
Last verified is the latest date Succeed checked the public details shown on this page. Program dates, prices and availability can still change.
How official sources are used
Succeed uses official provider information where available, then rewrites it into a student-facing summary for comparison and planning.
Why some dates are reference dates
If the current cycle is not available, Succeed may show the latest verified cycle dates so you can understand typical timing.
Succeed is independent from this provider unless a partnership is clearly stated.
Current status
Upcoming
Eligibility
No prerequisite coursework or experience
Age range / Year group
Ages 13+
Location / Region
Online
Cost
$495
Duration
6 weeks
Format
Online
Polygence’s Treating Cancer course introduces cancer biology, the immune system, and the treatment strategies behind cancer immunotherapy.
Students discuss scientific ideas, read primary research, and write an individual review about immunotherapy in a chosen cancer type. Group presentations add a collaborative element.
It suits students who want a guided introduction to biomedical research reading and writing before considering a more independent project.
Treating Cancer is a Polygence Pod focused on how the immune system can be used to treat cancer. Its curriculum connects basic cancer biology and immunology with antibodies, immune checkpoint inhibitors, and adoptive cell therapies. Live group sessions combine expert teaching with discussion.
Students also explore drug development, clinical trials, and why immunotherapy benefits some patient groups more than others. Each student chooses a cancer type and writes a review incorporating at least one primary research paper. Group presentations provide opportunities to collaborate alongside the individual written work.
The curriculum builds from biological foundations to treatment design, helping students connect mechanisms with medical decisions.
A UCLA Molecular Biology PhD leads the listed cohorts, bringing relevant subject expertise to discussions.
Using at least one primary research paper gives the final article a concrete research-reading requirement.
Clinical-trial navigation and treatment limitations encourage students to examine evidence beyond headline breakthroughs.
Individual reviews and group presentations combine independent writing with collaborative scientific communication.
Students curious about medicine and biology who want structured teaching, scientific discussion, and a first literature-review project.
You want laboratory experiments or a fully individualized research project, since this course centers on a shared curriculum and research reading.
This course is worth considering if guided explanations would help you move from an interest in cancer treatment to understanding research papers. The sequence links immune mechanisms, treatment design, clinical trials, and patient benefit, giving the final review a clear academic purpose.
Its value depends on completing the independent reading and writing, rather than simply attending discussions. The shared curriculum offers less freedom than an individual research mentorship, and the intended output is a literature review rather than original laboratory findings.
A practical overview of cost, time commitment, provider details, student outcomes and online support to review before deciding.
Cost and what is included
$495; includes Six one-hour expert-led group sessions., Lectures and group discussions., Course materials and Zoom recordings., A digital Pod workspace., Individual literature-review work and group presentations..
Dates and time commitment
6 weeks; 6×1-hour Tuesdays; 1–2+ hours independent work.
Provider details
Review the Polygence provider page and official sources before making a final decision.
What the student gains
Potential output: The main intended output is an article reviewing immunotherapy use in a cancer type of your choice.. Check whether feedback, certificate, recommendation or application evidence is included.
Online support and safeguarding
Check how online sessions are supervised, how mentor communication works, and what support route exists if the student needs help.
What to check before committing
Confirm current dates, session schedule, payment terms, cancellation rules, support expectations and what output or certificate is included with the provider.
Compare this program with similar options before deciding on dates, cost, format and fit.
Compare with similar programsEffort level
Moderate, with weekly teaching and independent research reading.
Best started
Ideally begin planning one to two weeks before your cohort starts to organize reading time and account setup.
Main challenge
Understanding a primary research paper well enough to explain its relevance to a chosen cancer type.
Review basic cell biology and make a short glossary of unfamiliar immune-system terms.
List a few cancer types you would like to understand, while staying flexible as the curriculum develops.
Reserve weekly time for reading and drafting alongside the scheduled session.
Review the workspace expectations and introduce yourself when you receive access.
Useful if
You want to test your interest in biomedical research before pursuing a more independent project.
You work through a guided sequence of cancer biology, immunology, treatment design, and clinical-trial concepts. Alongside discussions and group presentations, you develop an individual review of immunotherapy in a cancer type you choose.
Define cancer and review its hallmarks, treatment approaches, and common misconceptions.
Study immune-cell types, signaling, T-cell activation, and cancer immune evasion.
Compare antibodies, immune checkpoint inhibitors, and adoptive cell therapies.
Explore drug development and practice navigating clinical-trial information.
Examine treatment limitations, differences in patient benefit, and predictive biomarkers.
Use primary research to write your review and participate in group presentations.
Treating Cancer: Learn about cancer immunotherapy and explore where the field is headed — January 2026 cohort
6 January-10 February 2026
Tuesdays, 9:30pm EST/6:30pm PST; six one-hour sessions.
Treating Cancer: Learn about cancer immunotherapy and explore where the field is headed — May 2026 cohort
5 May-9 June 2026
Tuesdays, 9:00pm EDT/6:00pm PDT; six one-hour sessions.
Treating Cancer: Learn about cancer immunotherapy and explore where the field is headed — August 2026 cohort
2 August-6 September 2026
Sundays, 7:00pm EDT/4:00pm PDT; six one-hour sessions.
Treating Cancer: Learn about cancer immunotherapy and explore where the field is headed — October 2026 cohort
13 October-17 November 2026
Tuesdays, 9:00pm EDT/6:00pm PDT; six one-hour sessions.
| Milestone | Date | Timezone | Status | |
|---|---|---|---|---|
Treating Cancer: Learn about cancer immunotherapy and explore where the field is headed — January 2026 cohort | 6 January-10 February 2026 | Local | Past | |
Treating Cancer: Learn about cancer immunotherapy and explore where the field is headed — May 2026 cohort | 5 May-9 June 2026 | Local | Past | |
Treating Cancer: Learn about cancer immunotherapy and explore where the field is headed — August 2026 cohort | 2 August-6 September 2026 | Local | Past | |
Treating Cancer: Learn about cancer immunotherapy and explore where the field is headed — October 2026 cohort | 13 October-17 November 2026 | Local | Upcoming |
Participants must be at least 13 years old.
Under-18s require parental or legal-guardian supervision and agreement to terms.
No prerequisite coursework or previous research experience is required.
Confirm that the selected cohort's scheduled time works for you.
Program fee
$495 — Paid upfront at enrollment.
What's included
Six one-hour expert-led group sessions., Lectures and group discussions., Course materials and Zoom recordings., A digital Pod workspace., Individual literature-review work and group presentations.
Choose a cohort on the Treating Cancer course page.
Confirm that the scheduled session time works for you.
Complete the enrollment flow and pay tuition upfront at least one day before the first session.
Keep the enrollment confirmation email and use the workspace link sent seven days before the course starts.
Review the expectations and introduce yourself to your mentor and group.
Next step with Succeed
or let us know if .
Succeed replies first, usually within a working day
The course combines six weekly one-hour live online sessions with lectures and small-group discussion. Students complete at least 1–2 hours of independent work each week, use a digital workspace, and can catch up through materials and Zoom recordings.
Students are responsible for reviewing missed sessions and completing missed assignments.
Christopher, a UCLA PhD in Molecular Biology, leads the listed cohorts.
An assigned expert mentor guides the group through all six sessions.
Groups contain 2–6 students.
Sessions combine lectures with interactive discussion.
The shared workspace supports messaging and resource exchange between sessions.
Assignments build toward an individual literature review and group presentations.
Use an internet-connected computer or a compatible mobile device.
Set up your Polygence account before the first session.
Access the Pod workspace for materials, assignments, and recordings.
Learning centers on discussion, assignments, an individual literature review, and group presentations rather than grades or tests.
Main deliverable / output
The main intended output is an article reviewing immunotherapy use in a cancer type of your choice.
Include at least one primary research paper in your review.
Contribute to collaborative group presentations.
Compare a broader medicine introduction, an online medicine research option, and an in-person medical and biological sciences program.
An online introduction to medicine
Best for
Students comparing a broad medical introduction with a focused immunotherapy course.
An online research program focused on medicine
Best for
Students weighing a medicine research program against structured subject exploration.
Medical and biological sciences study in Cambridge
Best for
Students considering an in-person alternative with broader medical and biological coverage.
Save this program in Succeed to compare it with similar programs, dates, costs and formats in one place.
Compare with other programs
Content reviewed by
Co-founder, Succeed | Founder, Immerse Education (2012–2026)
Sean works at the intersection of academic enrichment, program quality and university preparation, with expertise in evaluating pre-university experiences for ambitious secondary school students.
Succeed uses official provider information where available, but keeps this public page focused on comparison and planning inside Succeed.
Course identity checked
Cohort dates reviewed
Tuition checked
Eligibility and terms reviewed
Weekly workload checked
Course outputs reviewed
Refund terms reviewed
We use source material to verify core facts, then show older cycle dates as reference when a current cycle is not available. Always check current application instructions before applying.
Treating Cancer: Learn about cancer immunotherapy and explore where the field is headed
by Polygence
Get the full picture before you decide
Succeed's assessment, estimated total cost and what applying involves.
No account needed for the Guide or Compare.